StocksFin Logo
BeiGene, Ltd. country of incorporation
|
|
Mr. John V. Oyler
|
9,000 employees
NASDAQ | Healthcare | Biotechnology
Henry Schein, Inc. country of incorporation
|
|
Mr. Stanley Bergman
|
22,000 employees
NASDAQ | Healthcare | Medical Distribution
Q322 reported Nov 9, 2022 Reporting Period
$387.63M 87.8% vs. Q321 Revenues Q322
-29.74% 68.2% vs. Q321 Gross Profit Margin
-143.84% ! 28.3% vs. Q321 Net Profit Margin
-690.56M ! -39.3% vs. Q321 Free Cash Flow Q322
$-5.33 ! -20.6% vs. Q321 EPS Q322
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q122
Q122 reported May 3, 2022 Reporting Period
$3.18B 8.7% vs. Q121 Revenues Q122
30.61% 0.5% vs. Q121 Gross Profit Margin
5.69% 0.3% vs. Q121 Net Profit Margin
74M 16.8% vs. Q121 Free Cash Flow Q122
$1.31 12% vs. Q121 EPS Q122
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q122
Loading...
Loading...
Loading...
Loading...
Ratios
As of
Sep 30, 2022
Mar 31, 2022
Quick Ratio
3.74
0.73
Current Ratio
4.07
1.79
Cash Ratio
2.97
0.06
Price to Book
3
3.33
Price to Sales
35.99
3.77
Price to Earnings
-6.26
16.53